DOC News Track the topics, authors and articles important to you
HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS
FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS
 QUICK SEARCH:   [advanced]


     


DOC News    December 1, 2007
Volume 4 Number 12 p. 7
© 2007 American Diabetes Association

Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldfarb, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Goldfarb, B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Two-hour Glucose Levels Predict Hypertension

Bruce Goldfarb

New evidence suggests that postprandial glucose levels may be key to cardiovascular risk. High 2-hour plasma glucose (2hPG) levels appear to raise the risk of developing hypertension within 5 years, according to an analysis of data from the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).

People with an average 2hPG of 115 mg/dl were about 36% more likely to develop hypertension within 5 years than those with an average 2hPG of 103 mg/dl, according to results presented at the European Association for the Study of Diabetes annual meeting, held September 18–21 in Amsterdam.

AusDiab involved 4,306 participants, with an average age of 47, who had a detailed medical exam and blood tests to measure glycemia and insulin levels. Over 5 years, 14% of the participants developed hypertension, defined as a pressure of ≥140 mmHg for systolic and ≥90 mmHg for diastolic.

Analysis of data showed a smooth linear relationship between 2hPG and hypertension over the 5-year period, with higher blood pressure associated with higher 2hPG even in the normal 2hPG range.

Interventions aimed at reducing the 2hPG level may "potentially yield additional benefits through reduction in hypertension," according to Elizabeth Barr, MPH, an epidemiologist at the International Diabetes Institute in Melbourne, Australia. {blacksquare}


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldfarb, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Goldfarb, B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS
FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS
DOC News Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum